Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/28/2025

Managing Medication Refill Requests Without Established Care

Patient Safety Concerns

  • The American Society of Clinical Oncology guidelines recommend not refilling medication unless verified with the prescriber and/or prescriber's agent and the patient/caregiver, especially in cases with a 2.5-year gap in care and documented non-adherence 1, 3, 4
  • The lack of current medical evaluation creates multiple critical safety concerns, including the inability to verify the patient's current medical status, potential drug interaction risks, and inappropriate dosing 1
  • The non-adherence pattern is unexplained, suggesting either the patient stopped taking the medications or there are significant barriers to care that need addressing 2, 3
  • Medical practice standards explicitly prohibit prescribing without proper patient evaluation, and the American College of Cardiology recommends verifying patient identity and medical status before refilling medications 1, 5
  • The ASCO/NCODA guidelines are unequivocal in stating that medications should not be refilled unless verified with the prescriber and/or prescriber's agent and the patient/caregiver 3, 4

Required Actions Before Refill

  • The patient should be contacted directly to verify their identity, determine why they stopped picking up medications, assess current symptoms and medical status, and schedule an urgent appointment 1, 2, 3, 4, 5
  • A comprehensive medication reconciliation should be conducted at the visit, including a brown bag review, verification of each medication's indication, dose, and necessity, and assessment for drug-drug and drug-disease interactions 1, 3, 4

Documentation Requirements

  • When declining a refill request, documentation should include the date and method of patient contact, reason for declining refill, appointment offered and patient's response, and any safety concerns discussed 2, 3, 4